Bimekizumab Tops Secukinumab for Plaque Psoriasis
In moderate-to-severe plaque psoriasis, bimekizumab is noninferior and superior to secukinumab and adalimumab, according to data from 2 studies.
Psoriasis
Premature Mortality Not Associated With Chronic or Increasing Pain Among Patients With Psoriatic Arthritis
Researchers sought to determine if a higher cumulative pain intensity is associated with premature mortality risk in patients with PsA.
Similar Rates of Depression and Anxiety Plus Depression With Apremilast vs Other Drugs in Psoriatic Arthritis
Apremilast used for the treatment of psoriasis or psoriatic arthritis is not associated with a high risk of incident treated depression, anxiety, or anxiety plus depression.
Real-World Study: Guselkumab May Be Effective for Moderate to Severe Plaque Psoriasis
Real-world data from patients with plaque psoriasis treated with guselkumab, who had previously been administered biologic agents is presented.
DermDx: Itchy Patches on the Hands
A 34-year-old man with a 10-year history of a chronic skin condition is referred for evaluation and treatment.
Psoriasis Increases Risk for Metabolic Syndrome and Coronary Plaque Burden
A novel study evaluated the effect of cardiometabolic syndrome on early vascular disease in patients with psoriasis.
PASI, BSA Involvement, and QoL Scales Best to Determine Psoriasis Severity
The correlation between physician-evaluated PASI and BSA involvement and patient-evaluated DLQI and PDI was evaluated in measuring psoriasis disease severity.
Weight Loss Linked to Reduced Disease Activity in Patients With Psoriatic Arthritis and Obesity
Researchers assessed the effects of weight loss on disease activity and cardiovascular risk factors in patients with psoriatic arthritis and obesity.
Subcutaneous Methotrexate vs Oral Treatment in Patients With Psoriasis
The effectiveness of oral vs subcutaneous methotrexate for the treatment of psoriasis in a registry is reported.
High IL-17 Levels Linked to Decreased Psoriatic Arthritis Risk
Researchers determined the causal associations between genetically predicted TNF-α, IL-12p70, and IL-17 levels and risk for psoriatic arthritis.
-
Loading...
-
Loading...
Next post in Rheumatology Information Center
